Skyrizi biosimilar availability or launch date?

When will Skyrizi (risankizumab) biosimilars be available?

Based on the information provided, I can’t confirm Skyrizi biosimilar launch or availability dates.

Which Skyrizi biosimilar products are expected, and when?

I don’t have the specific biosimilar names or any official timelines in the material available to me here, so I can’t reliably list expected products or their launch dates.

Has the company or regulators set a launch timeline yet?

No regulator-approved launch schedule (or confirmed approval date tied to a specific biosimilar) is included in the provided information, so I can’t verify whether a launch date has been set.

Are there patents or exclusivity rules that could delay biosimilar entry?

Patent/exclusivity timing can affect biosimilar launches, but I don’t have the relevant Skyrizi patent or exclusivity data in the information provided. If you want, share your country (U.S., EU, UK, Canada, etc.) and I can help you check the most relevant patent/exclusivity listings using DrugPatentWatch.com.
DrugPatentWatch.com (Skyrizi): https://www.drugpatentwatch.com/